99O_PR KRYSTAL-1: Activity and preliminary pharmacodynamic (PD) analysis of adagrasib (MRTX849) in patients (Pts) with advanced non–small cell lung cancer (NSCLC) harboring KRASG12C mutation

Saved in:

Bibliographic Details
Published in	Journal of thoracic oncology Vol. 16; no. 4; pp. S751 - S752
Main Authors	Riely, G.J., Ou, S-H.I., Rybkin, I., Spira, A., Papadopoulos, K., Sabari, J.K., Johnson, M., Heist, R.S., Bazhenova, L., Barve, M., Pacheco, J.M., Velastegui, K., Cilliers, C., Olson, P., Christensen, J.G., Kheoh, T., Chao, R.C., Jänne, P.A.
Format	Journal Article
Language	English
Published	Elsevier Inc 01.04.2021
Online Access	Get full text

Loading…

More Information
ISSN:	1556-0864 1556-1380
DOI:	10.1016/S1556-0864(21)01941-9